A delegation from the Zhejiang Provincial Drug Administration conducted a visit and investigation at Xingaojiyi.

On March 28th, members of the Party Leadership Group and the Drug Safety Director of the Zhejiang Provincial Drug Administration, Zhang Haijun, as well as the Department of Medical Devices, the Medical Device Review Center, the Medical Device Inspection Institute, the Ningbo Municipal Administration for Market Regulation, and the Yuyao Municipal Administration for Market Regulation, conducted a research, service and problem-solving activity at Xingaoji.

The research team was accompanied by Mr. Gao Dajian, the chairman of Xinggaoyi. They visited the production line and product display area of Xinggaoyi, and conducted a survey on the characteristics and technical advantages of Xinggaoyi's liquid helium-free magnetic resonance products, as well as the development situation of the domestic and international markets in recent years. The research team unanimously believed that Xinggaoyi's liquid helium-free magnetic resonance technology not only solved the bottleneck problem of lacking liquid helium resources in China, but also had significant clinical value and should be vigorously promoted.

During the inspection process, the magnetic resonance remote monitoring system independently developed by Xing Gaoyi was also highly praised by Director Zhang Haijun. This monitoring system uses Internet of Things technology to monitor the operating status and check the parameters of all Xing Gaoyi magnetic resonance equipment across the country. When an abnormality occurs with a certain device, the monitoring system will automatically notify the maintenance personnel and users through text messages, WeChat, voice calls, etc., and immediately inform them of the alarm information, while also recording the abnormal data status. Director Zhang Haijun stated that this is an extremely effective means to ensure the safety of medical equipment usage, allowing medical staff and patients to use the equipment with peace of mind.

Subsequently, a symposium was held. Chairman Gao Daojian and Vice President Zhu Jianfeng of Xingaojiyue presented an overview of the successful listing of the non-liquid helium magnetic resonance product as a national third-class innovative product and the continuous innovation efforts of the company. A number of leaders highly praised the innovative spirit of the enterprise and sincerely inquired about the difficulties encountered in the company's development and product research and development. They actively encouraged and supported the company to leverage its own advantages, achieve independent innovation and industrial upgrading, and compete with international giants.

Since the company's liquid helium-free magnetic resonance product obtained the national Class III innovative medical device registration certificate in April 2022, it has been committed to transforming the liquid helium-free magnetic resonance technology into clinical application innovations. In February this year, the company's new generation of liquid helium-free magnetic resonance product - Spin MRI multi-posture imaging magnetic resonance - was approved by the National Medical Products Administration as a priority approval project for medical devices, and will soon obtain the registration certificate and be launched on the market.

Head imaging with 3.0T magnetic resonance, as well as multiple other liquid helium-free magnetic resonance products such as those specifically designed for combined operating rooms, have all entered the prototype debugging stage and have achieved new clinical value.

Xinggaoyi will gradually introduce more liquid helium-free magnetic resonance products with significant clinical value, providing the public with green, precise and efficient medical services.